The Evolution of DTP Pharmacy Models and the Future of Digital Health

Описание: The pharmacy landscape is undergoing a major transformation as digital health, new payment models, and direct-to-patient (DTP) channels rapidly evolve. In this episode of Over the Counter, host Brian Nowosielski sits down with 3 leading experts to unpack what this shift really means for patients, pharmacies, pharma manufacturers, and payers.

Guests:

Timothy Aungst, PharmD – Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences; Founder, The Digital Apothecary
Ravi Patel, PharmD – Pharmacist at Blueberry Pharmacy; Digital health expert focused on reimagining health care delivery
Smit Patel, PharmD – Pharmacist and Professor, Brown-Lifespan Center for Digital Health; AI and digital health expert; Advisor to The Economist Impact

In this conversation, we cover:

What Direct-to-Patient (DTP) pharmacy models are and how they differ from Direct-to-Consumer (DTC) and Direct-to-Employer (DTE) models
Why DTP has gained momentum and how pharma manufacturers are reshaping traditional drug distribution
How federal policies (including initiatives like TrumpRx and most-favored-nation drug pricing concepts) aim to improve pricing transparency and patient access
The potential impact of DTP on PBMs, independent/community pharmacies, and retail chains
Key challenges around medication reconciliation, fragmented data, and continuity of care as more drugs flow through nontraditional channels
Economic, operational, and clinical questions pharmacy leaders must confront over the next 3–5 years
How the future of pharmacy is shifting from location-based dispensing to function- and service-based models integrated into a digital ecosystem

If you’re a pharmacist, policymaker, pharma leader, or just curious about where pharmacy is headed, this discussion offers a clear, forward-looking view of the opportunities and risks in DTP models—and what needs to happen next to protect patients while innovating care.